Literature DB >> 17318070

Endothelial dysfunction and fetuin A levels before and after kidney transplantation.

Kayser Caglar1, Mahmut Ilker Yilmaz, Mutlu Saglam, Erdinc Cakir, Selim Kilic, Tayfun Eyileten, Alper Sonmez, Yusuf Oguz, Koksal Oner, Fatih Ors, Abdulgaffar Vural, Mujdat Yenicesu.   

Abstract

BACKGROUND: Endothelial dysfunction (ED) has a major role in the cardiovascular outcome of patients with chronic kidney disease (CKD). The aim of this study was to investigate the relation between fetuin A levels and ED in kidney transplant recipients.
METHODS: Forty-two living donor kidney transplant recipients, 21 (11 male) on cyclosporine A and 21 (10 male) on tacrolimus-based regimes, were studied. Forty-two (21 male) healthy subjects were enrolled as controls. Fetuin A, highly sensitive C-reactive protein (hsCRP) levels, brachial artery endothelium-dependent vasodilatation (FMD), nitroglycerine mediated dilatation (NMD), and carotid intima-media thickness (CIMT) were measured before transplantation and on the 30th and 90th days posttransplant.
RESULTS: Pretransplantation serum fetuin A concentrations and FMD values of patients were significantly lower than those of the controls (P<0.001 for both). These were significantly increased in the 30th and 90th days posttransplantation There was a significant positive correlation between Fetuin A and FMD levels both before and after kidney transplantation (r=0.534, r=0.576; respectively, P<0.001 for both). Carotid intima-media thickness and hsCRP levels decreased after transplantation (P<0.001 for all). According to the regression analysis, fetuin A, intact parathyroid hormone, and hsCRP levels were the independent determinants of FMD.
CONCLUSION: The results of the present study suggest that low serum fetuin A levels in CKD may contribute to impaired endothelial functions in CKD. Future studies should clarify the role of fetuin A levels in cardiovascular outcomes of CKD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318070     DOI: 10.1097/01.tp.0000251647.72673.c7

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

1.  Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study.

Authors:  Piya Chaemsaithong; Roberto Romero; Adi L Tarca; Steven J Korzeniewski; Alyse G Schwartz; Jezid Miranda; Ahmed I Ahmed; Zhong Dong; Sonia S Hassan; Lami Yeo; Tinnakorn Tinnakorn
Journal:  J Matern Fetal Neonatal Med       Date:  2014-09-29

Review 2.  Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions.

Authors:  Uwe Christians; Jost Klawitter; Jelena Klawitter; Nina Brunner; Volker Schmitz
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-02       Impact factor: 4.481

3.  Assessment of the cardiovascular system in pediatric chronic kidney disease: a pilot study.

Authors:  Jutta Muscheites; Andreas Alexander Meyer; Erdmute Drueckler; Marianne Wigger; Dagmar-Christiane Fischer; Guenther Kundt; Wolfgang Kienast; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2008-07-03       Impact factor: 3.714

4.  Soluble endothelial cell protein C receptor and thrombomodulin levels after renal transplantation.

Authors:  Kenan Keven; Semiha Elmaci; Sule Sengul; Nejat Akar; Yonca Egin; Volkan Genc; Sehsuvar Erturk; Bulent Erbay
Journal:  Int Urol Nephrol       Date:  2009-10-03       Impact factor: 2.370

5.  Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients.

Authors:  Kayser Caglar; Mahmut Ilker Yilmaz; Mutlu Saglam; Erdinc Cakir; Cengizhan Acikel; Tayfun Eyileten; Mujdat Yenicesu; Yusuf Oguz; Abdulgaffar Vural; Juan Jesus Carrero; Jonas Axelsson; Bengt Lindholm; Peter Stenvinkel
Journal:  Clin J Am Soc Nephrol       Date:  2007-12-05       Impact factor: 8.237

6.  Cardiac and vascular structure and function parameters do not improve with alternate nightly home hemodialysis: an interventional cohort study.

Authors:  Carolyn L van Eps; Leanne Jeffriess; Brian Haluska; Carmel M Hawley; Jeffrey Coombes; Aya Matsumoto; Janine K Jeffries; David W Johnson; Scott B Campbell; Nicole M Isbel; David W Mudge; Thomas Marwick
Journal:  BMC Nephrol       Date:  2011-10-03       Impact factor: 2.388

7.  Causal association pathways between fetuin-A and kidney function: a mediation analysis.

Authors:  Philip Etabee Bassey; Pawin Numthavaj; Sasivimol Rattanasiri; Piyamitr Sritara; Mark McEvoy; Boonsong Ongphiphadhanakul; Ammarin Thakkinstian
Journal:  J Int Med Res       Date:  2022-04       Impact factor: 1.573

8.  Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients.

Authors:  Panagiotis Pateinakis; Aikaterini Papagianni; Stella Douma; Georgios Efstratiadis; Dimitrios Memmos
Journal:  BMC Nephrol       Date:  2013-06-12       Impact factor: 2.388

Review 9.  Cardiac and vascular changes with kidney transplantation.

Authors:  A Ali; I Macphee; J C Kaski; D Banerjee
Journal:  Indian J Nephrol       Date:  2016 Jan-Feb
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.